pharma · Mild/non-serious osteoarthritis (OA) of the knee.
Haleon - Gebro
HALEON AUSTRALIA PTY LTD
HALEON AUSTRALIA PTY is a pharma organization headquartered in AU. Primary therapeutic focus areas include Mild/non-serious osteoarthritis (OA) of the knee.. NovaPharmaNews links 3 clinical program(s), 1 drug profile(s),
Fieberbrunn, AU HQ
179 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Fieberbrunn, AU
- Employees
- 179
- Programs
- 3
- Drugs
- 9
- Patents
- 0
300128
Approved · small molecule · Mild/non-serious osteoarthritis (OA) of the knee.
300128 for Mild/non-serious osteoarthritis (OA) of the knee. is a Approved program (small_molecule) at HALEON AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Internal code 300128
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- HALEON AUSTRALIA PTY LTD
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Mild/non-serious osteoarthritis (OA) of the knee.
- Status
- active
- Trials
- 1